With well over 100,000-square-feet of GMP R&D, pilot plant, and cGMP manufacturing space based in the US, LGM Pharma is uniquely suited to support reshoring of pharmaceutical outsourcing initiatives. We possess state-of-the-art commercial scale-up facilities and equipment for comprehensive, cost-effective pharmaceutical development and manufacturing, including DEA Class II-V manufacturing. As well as analytical method development and validation and stability studies.
Our facilities are up-to-date on inspections and approvals with no negative reports or observations.
We pack a lot into this 16,000-square-foot R&D facility: it’s where we formulate and develop drug products prior to tech transfer for manufacturing and packaging in our California and Texas facilities. We also manufacture solid dosage forms for R&D.
With three U.S. locations, LGM Pharma is uniquely capable of reshoring your drug product development and manufacturing. Our facilities and equipment enable us to formulate, develop, manufacture, and package up through commercial scale a wide range of drug formulations. And move them quickly to market.